| For: | Nishimura T, Okano T, Naito M, Tsuji C, Iwanaka S, Sakakura Y, Yasuma T, Fujimoto H, D'Alessandro-Gabazza CN, Oomoto Y, Kobayashi T, Gabazza EC, Ibata H. Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report. World J Clin Cases 2021; 9(23): 6922-6928 [PMID: 34447843 DOI: 10.12998/wjcc.v9.i23.6922] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i23/6922.htm |
| Number | Citing Articles |
| 1 |
Jenny Huang, Andrew A. White. Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis. Immunology and Allergy Clinics of North America 2024; 44(4) doi: 10.1016/j.iac.2024.07.006
|
| 2 |
Koichiro Asano, Katsuyoshi Tomomatsu, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma. Treatment of allergic bronchopulmonary aspergillosis with biologics. Chinese Medical Journal Pulmonary and Critical Care Medicine 2025; 3(1) doi: 10.1016/j.pccm.2024.11.005
|
| 3 |
Jeremy Stuart Brown, Darius Armstrong-James, Jonathan Ayling-Smith, Matthijs Backx, Meg Coleman, David Connell, Paddy Dennison, Damian G Downey, Fiona Lynch, Wei Shen Lim, Jenny White, Caroline Baxter. British Thoracic Society Clinical Statement onAspergillus-related chronic lung disease. Thorax 2025; 80(Suppl 1) doi: 10.1136/thorax-2024-222567
|
| 4 |
Katsuyoshi Tomomatsu, Hirotaka Yasuba, Takashi Ishiguro, Shiro Imokawa, Johsuke Hara, Seiko Soeda, Norihiro Harada, Naomi Tsurikisawa, Naohiro Oda, Shigeki Katoh, Takanori Numata, Yasuteru Sugino, Mitsuhiro Yamada, Mitsuhiro Kamimura, Takeshi Terashima, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma, Koichiro Asano. Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32246-8
|
| 5 |
Sara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo, Salvatore Leonardi. Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review. European Respiratory Review 2022; 31(165) doi: 10.1183/16000617.0011-2022
|
| 6 |
Tsuguhisa Nakayama, Jun Miyata, Natsuki Inoue, Shigeharu Ueki. Allergic fungal rhinosinusitis: What we can learn from allergic bronchopulmonary mycosis. Allergology International 2023; 72(4) doi: 10.1016/j.alit.2023.06.005
|
| 7 |
Solange Oliveira Rodrigues Valle, Augusto Sarquis Serpa, Faradiba Sarquis Serpa. Aspergillus and Aspergillosis - Advances in Genomics, Drug Development, Diagnosis and Treatment. Infectious Diseases 2023; 25 doi: 10.5772/intechopen.112166
|
| 8 |
Jeeyeon Kim, Henry W. Barnes, Kayla Jung, Jesus Uribe, Maria del Carmen Reyes, Mary Alice Gajo, Joy E. Gibson, Jonathan Tam, Elizabeth B. Burgener. Treatment of Allergic Bronchopulmonary Aspergillosis with Dupilumab Reduces IgE Levels and is Well Tolerated in Three Children with Cystic Fibrosis. Pediatric Allergy, Immunology, and Pulmonology 2026; doi: 10.1177/2151321X261487234
|
| 9 |
Luis Pérez de Llano, David Dacal Rivas, Ian Pavord, Mian Muhammad Salman Aslam, Njira Lugogo. Biologics Use in Eosinophilic Lung Disease: Controversies and Consensus. The Journal of Allergy and Clinical Immunology: In Practice 2026; 14(3) doi: 10.1016/j.jaip.2026.01.022
|
| 10 |
Hye-Jin Park, Sung-Dong Kim, Eun-Jung Cho, Kyu-Sup Cho. A Case of Concomitant Occurrence of Eosinophilic Mucin
Rhinosinusitis and Allergic Bronchopulmonary Aspergillosis Managed with
Dupilumab after Endoscopic Sinus Surgery. Journal of Clinical Otolaryngology Head and Neck
Surgery 2023; 34(4) doi: 10.35420/jcohns.2023.34.4.205
|
| 11 |
Yasutaka Kawasaki, Kazuaki Nishiki, Takeshi Ishizaki. Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis. Respiratory Medicine Case Reports 2024; 47 doi: 10.1016/j.rmcr.2023.101964
|
| 12 |
Toshiyuki Sumi, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Yuichi Yamada, Hirofumi Chiba. Successful Treatment of Mucus Plug Due to Allergic Bronchopulmonary Aspergillosis Using Dupilumab. Cureus 2024; doi: 10.7759/cureus.55884
|
| 13 |
Koichiro Asano, Tsuyoshi Oguma. Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?. Internal Medicine 2025; 64(4) doi: 10.2169/internalmedicine.4386-24
|
| 14 |
Ryuta Onozato, Jun Miyata, Takanori Asakura, Ho Namkoong, Koichiro Asano, Naoki Hasegawa, Koichi Fukunaga. Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial‐pulmonary disease successfully treated with dupilumab: A case report and literature review. Respirology Case Reports 2024; 12(7) doi: 10.1002/rcr2.1432
|
| 15 |
Pedro A. Lamothe, Charles Lewis Humphrey Pruett, Natalia Smirnova, Aaron Shepherd, Martin C. Runnstrom, Jiwon Park, Rebecca H. Zhang, Leshan Zhao, Colin Swenson, F. Eun-Hyung Lee. Anti–IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology: Global 2025; 4(1) doi: 10.1016/j.jacig.2024.100369
|
| 16 |
Richard B. Moss. Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals. Journal of Fungi 2023; 9(1) doi: 10.3390/jof9010085
|
| 17 |
Xiaoying Chen, Haopeng Zhi, Xiaohu Wang, Zicong Zhou, Huiting Luo, Jing Li, Roma Sehmi, Paul M. O’Byrne, Ruchong Chen. Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. Lung 2024; 202(4) doi: 10.1007/s00408-024-00717-y
|
| 18 |
Yoshiro Kai, Masanori Yoshikawa, Masayuki Matsuda, Kentaro Suzuki, Masato Takano, Kazuya Tanimura, Nobuhiro Fujioka, Yukio Fujita, Shigeo Muro. Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report. Respiratory Medicine Case Reports 2022; 39 doi: 10.1016/j.rmcr.2022.101723
|